National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No. 3) 2020 (Cth)

National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No.3) 2020

I, Tania Rishniw, delegate of the Minister for Health, make the following Determination.

Dated  27 August 2020

Tania Rishniw

Deputy Secretary

Primary and Community Care Group

Department of Health

Contents

1  Name.................................................................................................. 2

2  Commencement.................................................................................. 2

3  Authority............................................................................................ 2

4  Schedules............................................................................................ 2

Schedule 1—Amendments  3

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)         3

1  Name

This instrument is the National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No.3) 2020.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	The day after this instrument is registered.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsections 9B(2) and (5) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)

1  Subsection 7(7A)

Repeal the subsection.

2  Subsection 7(8)

Omit “207B”, substitute “207A, 207B and 207F”.

3  Subsection 7(8B)

Repeal the subsection.

4Part 1 of Schedule 1 (after table item 108A)

Insert:

108B Vaccine
Meningococcal (Groups A,C,W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine (Men ACWY-CRM)
Circumstances
Vaccine may be provided to: (a) a person aged at least 14 years old but less than 17 years old as part of a school based program; or (b) a person aged at least 14 years old but less than 19 years old who did not receive the vaccination as part of a school based program. Menveo Injection (0.5mL) Each 0.5 mL reconstituted dose contains: ·     (a) 10 µg Meningococcal polysaccharide serogroup A conjugated to 16.7–33.3 µg Corynebacterium diphtheriae CRM197 protein ·     (b) 5 µg Meningococcal polysaccharide serogroup C conjugated to 7.1–12.5 µg C. diphtheriae CRM197 protein ·     (c) 5 µg Meningococcal polysaccharide serogroup W-135 conjugated to 3.3–8.3 µg C. diphtheriae CRM197 protein ·     (d) 5 µg Meningococcal polysaccharide serogroup Y conjugated to 5.6–10 µg C. diphtheriae CRM197 protein 1 dose

5  Part 2 of Schedule 1 (table item 207A, column headed “Vaccine and the circumstances in which vaccine may be provided”, under the subheading “Circumstances”)

Omit “subsection 7(7A)”, substitute “subsection 7(8)”.

6  Part 2 of Schedule 1 (table item 207F, column headed “Vaccine and the circumstances in which vaccine may be provided”, under the subheading “Circumstances”)

Omit “subsection 7(8B)”, substitute “subsection 7(8)”.